Immunoinformatics approach to engineer a multi-epitope vaccine against SdrG in skin commensal Staphylococcus epidermidis
PLOS One · 2026
DOI: 10.1371/journal.pone.0327534 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Shahina Akter und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Staphylococcus epidermidis, Epitopes, Bacterial Proteins, Staphylococcal Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The human skin serves as a dynamic ecosystem for beneficial commensal bacteria such as Staphylococcus epidermidis , which play a crucial role in maintaining skin barrier integrity and modulating immune responses. Remarkably, recent research has demonstrated that the skin can function as a natural vaccination site, producing specific antibodies against commensal microbes without inducing inflammation. However, S. epidermidis can transition into an opportunistic pathogen in clinical settings, forming resilient biofilms on medical implants and exhibiting increasing resistance to antibiotics (MRSE), posing a significant healthcare challenge. To address this challenge, advanced immunoinformatics strategies were leveraged to design a novel multi-epitope vaccine targeting the SdrG protein, a key mediator of S. epidermidis biofilm formation. The vaccine’s binding dynamics with Toll-like receptor 4 (TLR4) were evaluated through computational analyses, including molecular docking and 500-nanosecond molecular dynamics (MD) simulations. Stability assessments via Root Mean Square Deviation (RMSD), Root Mean Square Fluctuation (RMSF), and Radius of Gyration (Rg) confirmed that the vaccine-TLR4 complex achieved structural equilibrium, with TLR4 maintaining rigidity while the vaccine exhibited adaptive flexibility for optimal binding. The Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) method revealed a strong binding affinity, with a peak free energy of −52.73 kcal/mol and an average of −24.72 ± 9.5989 kcal/mol over the last 50 ns, indicating a thermodynamically favorable interaction. Furthermore, in silico cloning validated the vaccine’s expressibility, with successful integration into the pET-Sangamo-His vector (8560 bp) for optimal E. coli production. These findings underscore the vaccine’s potential to elicit a robust immune response by stably engaging TLR4, a critical step in innate immune activation. By combining computational precision with immunological insights, this study lays a foundation for developing an effective prophylactic strategy against S. epidermidis biofilm-associated infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Bangladesh Council of Scientific and Industrial Research (BCSIR), Dhaka, Bangladesh.
- Department of Biophysics and Pharmacology, Bioscience Center, Federal University of Rio Grande do Norte, Natal/RN, Brazil.
- State Key Laboratory of Microbial Diversity and Innovative Utilization, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
ORCID-Profile: Shahina Akter
Zitieren
APA
Akter, S., Silva, G. V. R., Oliveira, J. I. N., Fulco, U. L., Xu, X., & Fu, Y. V. (2026). Immunoinformatics approach to engineer a multi-epitope vaccine against SdrG in skin commensal Staphylococcus epidermidis. PLOS One. https://doi.org/10.1371/journal.pone.0327534
Vancouver
Akter S, Silva GVR, Oliveira JIN, Fulco UL, Xu X, Fu YV. Immunoinformatics approach to engineer a multi-epitope vaccine against SdrG in skin commensal Staphylococcus epidermidis. PLOS One. 2026. doi:10.1371/journal.pone.0327534
BibTeX
@article{Akter2026,
author = {Akter, Shahina and Silva, Gabriel Vinícius Rolim and Oliveira, Jonas Ivan Nobre and Fulco, Umberto Laino and Xu, Xianyang and Fu, Yu Vincent},
title = {Immunoinformatics approach to engineer a multi-epitope vaccine against SdrG in skin commensal Staphylococcus epidermidis},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0327534}
}
EUVIMED